𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐧𝐨𝐭𝐢𝐜𝐞
𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐯𝐚𝐜𝐜𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐮𝐩𝐝𝐚𝐭𝐞
𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟒, 𝟐𝟎𝟐𝟏
We would like to inform everyone that the COVID-19 vaccination for the walk-in individuals of 12 years and above will be discontinued starting 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟏, 𝟐𝟎𝟐𝟏.
This is in keeping with the fact that most of the eligible and consenting population have been vaccinated, and also considering the logistic challenges related to the vaccine.
The health ministry will, however, continue to administer COVID-19 vaccines for:
1. Children as and when they turn 12 years.
2. All those who enter the country with no or partial vaccination.
3. Administer second dose for those who have received the first dose. Second dose for ages 12 to 17 years will be provided in the second and third week of October. This will take the total vaccine coverage to about 80 percent. An update will be shared soon after.
4. Those who were unable to take the vaccine so far due to unavoidable social or health reasons such as acute illness or being pregnant or breast feeding at the time.
We would like to reiterate here that the vaccine is safe for pregnant and lactating women, and many have also come forward until now. Unless specified otherwise by the treating physician, there are no medical conditions that restrict individuals from taking the COVID-19 vaccination.
Please note that all eligible individuals who are not vaccinated yet can choose to take the vaccine within October 2021.
The government will also arrange vaccines for children below 12 years, as and when the international and national regulatory bodies approve. Announcements will be made accordingly.
Should there be major changes in the global COVID-19 vaccine scenario and trend, we will work towards a vaccination campaign for the entire population at a different time. For now, we do not encourage booster doses beyond the second dose, until stronger evidence evolves.
We encourage everyone to continue practicing health habits of washing hands, wearing masks and keep away from crowd to avoid potential threats as the pandemic persists with the same risks.
